Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Virological features associated with the development of broadly neutralizing antibodies to HIV-1.

Trends in microbiology - 1 Apr 2015

Moore Penny L, Williamson Carolyn, Morris Lynn

Abstract excerpt

The development of a preventative HIV-1 vaccine remains a global public health priority. This will likely require the elicitation of broadly neutralizing antibodies (bNAbs) able to block infection by diverse viral strains from across the world. Understanding the pathway to neutralization breadth in HIV-1 infected humans will provide insights into how bNAb lineages arise, a process that probably involves a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS Vaccines
Share to Antibodies, Neutralizing
Share to env Gene Products, Human Immunodeficiency Virus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epitopes

Share to HIV Antibodies

Share to HIV Infections

Share to South Africa

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 25572881
DOI: 10.1016/j.tim.2014.12.007
PMCID: PMC4380704

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Virological features associated with the development of broadly neutralizing antibodies to HIV-1.PMID 25572881Read ↗

Determinants of HIV-1 broadly neutralizing antibody induction.Semantic proximity Read ↗

Harnessing the protective potential of HIV-1 neutralizing antibodiesSemantic proximity Read ↗

Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune ResponseSemantic proximity Read ↗

Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development.Semantic proximity Read ↗

Catch Me If You Can--The Race Between HIV and Neutralizing Antibodies.Semantic proximity Read ↗

<scp>HIV</scp>‐1 neutralizing antibodies: understanding nature's pathwaysSemantic proximity Read ↗

Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies.Semantic proximity Read ↗

Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infectionSemantic proximity Read ↗

Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention.Semantic proximity Read ↗

Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potentialSemantic proximity Read ↗

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.Semantic proximity Read ↗

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.